Abstract
Despite incredible advancement made in recent years, treatment of cancer still remains the most challenging task for the mankind. The new small molecule therapeutic drugs are more specific, exhibit better therapeutic efficacy and mostly contain scaffolds of β-lactam, sulfonamide, quinoline, quinazoline, quinoxaline, purine, pyrimidine, resorcinol, pyrazole/isoxazole, benzamide etc. The structure-activity relationships of different pharmacophores that have been reported to potently inhibit cell growth of human tumour cell lines are constantly being investigated. Development of products of natural origin can also prove effective without submitting to harmful radiation and chemotherapy treatments. Under these circumstances, the practicing organic chemists are greatly facing the challenge of designing new and leading anti-cancer drugs based on natural products and scaffolds of potent pharmacaophores. The review intends to cover new approach of anti-cancer drug design using natural and synthetic pharmacophores. The plausible synthetic routes to major drugs for oncology that were approved recently by Food and Drug Administration (FDA) are also discussed.
Keywords: Anti-cancer drug, phamacophoric scaffold, oncology, synthesis, natural & herbal product, hybrid drug, FDA-approved drug.
Current Organic Chemistry
Title:Anti-Cancer Drug Design Using Natural and Synthetic Pharmacophores
Volume: 19 Issue: 15
Author(s): Pinaki S. Bhadury and Jun Pang
Affiliation:
Keywords: Anti-cancer drug, phamacophoric scaffold, oncology, synthesis, natural & herbal product, hybrid drug, FDA-approved drug.
Abstract: Despite incredible advancement made in recent years, treatment of cancer still remains the most challenging task for the mankind. The new small molecule therapeutic drugs are more specific, exhibit better therapeutic efficacy and mostly contain scaffolds of β-lactam, sulfonamide, quinoline, quinazoline, quinoxaline, purine, pyrimidine, resorcinol, pyrazole/isoxazole, benzamide etc. The structure-activity relationships of different pharmacophores that have been reported to potently inhibit cell growth of human tumour cell lines are constantly being investigated. Development of products of natural origin can also prove effective without submitting to harmful radiation and chemotherapy treatments. Under these circumstances, the practicing organic chemists are greatly facing the challenge of designing new and leading anti-cancer drugs based on natural products and scaffolds of potent pharmacaophores. The review intends to cover new approach of anti-cancer drug design using natural and synthetic pharmacophores. The plausible synthetic routes to major drugs for oncology that were approved recently by Food and Drug Administration (FDA) are also discussed.
Export Options
About this article
Cite this article as:
S. Bhadury Pinaki and Pang Jun, Anti-Cancer Drug Design Using Natural and Synthetic Pharmacophores, Current Organic Chemistry 2015; 19 (15) . https://dx.doi.org/10.2174/1385272819666150525234749
DOI https://dx.doi.org/10.2174/1385272819666150525234749 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
p38 MAPK: A Potential Target of Chronic Pain
Current Medicinal Chemistry Carotenoids and Modulation of Cancer: Molecular Targets
Current Pharmacogenomics Nanotechnological Advances in the Treatment of Epilepsy
CNS & Neurological Disorders - Drug Targets Tocilizumab Labeling with 99mTechnetium via HYNIC as a Molecular Diagnostic Agent for Multiple Myeloma
Anti-Cancer Agents in Medicinal Chemistry Epigenetic Mechanism Involved in the HBV/HCV-Related Hepatocellular Carcinoma Tumorigenesis
Current Pharmaceutical Design Nociceptin / Orphanin FQ (NOP) Receptors as Novel Potential Target in the Treatment of Gastrointestinal Diseases
Current Drug Targets Recent Patents on Light Based Therapies: Photodynamic Therapy, Photothermal Therapy and Photoimmunotherapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Lipoxygenase Inhibitors for Cancer Prevention: Promises and Risks
Current Pharmaceutical Design Tumor Escape from Immune Response: Mechanisms and Targets of Activity
Current Drug Targets Targeting the Ubiquitin-Proteasome Pathway: An Emerging Concept in Cancer Therapy
Current Topics in Medicinal Chemistry Advances on PPARγ Research in the Emerging Era of Precision Medicine
Current Drug Targets Identification of Drug Candidates for Breast Cancer Therapy Through Scaffold Repurposing: A Brief Review
Current Drug Research Reviews ADAM10 as a Therapeutic Target for Cancer and Inflammation
Current Pharmaceutical Design Synthesis of Aza-BODIPY Boron Difluoride PDT Agents to Promote Apoptosis in HeLa Cells
Letters in Organic Chemistry Transmembrane Phosphatases and Cancer Development, the Role of Protein Tyrosine Phosphatase-kappa (PTPκ) and Protein Tyrosine Phosphatase-mu (PTPμ)
Current Signal Transduction Therapy Current Uses of Robotic Surgery for the Treatment of Benign Adnexal Conditions
Current Women`s Health Reviews Opioid Free Anaesthesia and Cancer
Current Pharmaceutical Design Prognostic Value of CD34 Positive Cells in the Lumen of Tumor Vessels in Breast Cancer
Current Angiogenesis (Discontinued) Aloperine Induces Apoptosis by a Reactive Oxygen Species Activation Mechanism in Human Ovarian Cancer Cells
Protein & Peptide Letters Applications of Nanomaterials for Cancer Treatment: Recent Patents Review
Recent Patents on Nanomedicine